TITLE

Modern concept of vascular cognitive impairment

PUB. DATE
September 2007
SOURCE
British Medical Bulletin;Sep2007, Vol. 83 Issue 1, p291
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Vascular cognitive impairment (VCI) has superseded vascular dementia and multi-infarct dementia as the concept to be used in cognitive decline due to cerebrovascular disease. Method The literature was reviewed with regard to the concept of VCI and its incidence, pathophysiological substrate, clinical features and management. Results A change in the diagnostic paradigm from the current Alzheimer-based definition of vascular dementia to VCI will allow the earlier identification of cases and will identify a different population from that recognized using the current criteria for vascular dementia. Conclusions Case identification at the earliest possible stage affords the greatest opportunity for treatment that may slow the rate of progression.
ACCESSION #
27303609

 

Related Articles

  • Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Bruce R. Reed; Dan M. Mungas; Joel H. Kramer; William Ellis; Harry V. Vinters; Chris Zarow; William J. Jagust; Helena C. Chui // Brain: A Journal of Neurology;Mar2007, Vol. 130 Issue 3, p731 

    Differentiating the cognitive effects of cerebrovascular disease, particularly small vessel disease, from those of Alzheimer''s disease is a difficult clinical challenge. An influential model of how subcortical cerebrovascular disease causes cognitive dysfunction posits that damage to...

  • Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease. Small, Gary; Erkinjuntti, Timo; Kurz, Alexander; Lilienfeld, Sean // CNS Drugs;2003, Vol. 17 Issue 12, p905 

    Introduction: Alzheimer's disease and vascular dementia are the two most common types of dementia, with significant overlap of clinical symptoms and pathology. Previous results from a 6-month, double-blind, placebo-controlled, international, multicentre study of the cholinomimetic...

  • Flavonoids and the Brain: Evidences and Putative Mechanisms for a Protective Capacity. Dajas, F.; Arredondo, F.; Echeverry, C.; Ferreira, M.; Morquio, A.; Rivera, F. // Current Neuropharmacology;Jul2005, Vol. 3 Issue 3, p193 

    The origin and/or the evolution of brain diseases of high morbidity and mortality such as cerebrovascular diseases, Alzheimer's Dementia or Parkinson's disease have been linked to oxidative stress. Epidemiological or clinical descriptive studies have shown that diets with predominant vegetarian...

  • Cerebrovascular Damage as a Cause for Alzheimer's Disease. Humpel, Christian; Marksteiner, Josef // Current Neurovascular Research;Oct2005, Vol. 2 Issue 4, p341 

    Alzheimer's disease is a progressive brain disorder that gradually destroys a patient's memory function and ability to carry out daily activities. According to the prevailing amyloid cascade hypothesis, Alzheimer's disease is initiated by amyloid �-peptide accumulation leading to neuronal...

  • Delaying dementia.  // Speech & Language Therapy in Practice;Autumn2009, p2 

    The article reports on the joint forces of Alzheimer's Society and the Stroke Association in funding research in Great Britain. Both associations have worked together to be able to help prevent or delay the development of dementia among people who had stroke. The goals of the association have...

  • Hippocampal complex atrophy in poststroke and mild cognitive impairment. Selnes, Per; Grambaite, Ramune; Rincon, Mariano; Bjørnerud, Atle; Gjerstad, Leif; Hessen, Erik; Auning, Eirik; Johansen, Krisztina; Almdahl, Ina S; Due-Tønnessen, Paulina; Vegge, Kjetil; Bjelke, Börje; Fladby, Tormod // Journal of Cerebral Blood Flow & Metabolism;Nov2015, Vol. 35 Issue 11, p1729 

    To investigate putative interacting or distinct pathways for hippocampal complex substructure (HCS) atrophy and cognitive affection in early-stage Alzheimer's disease (AD) and cerebrovascular disease (CVD), we recruited healthy controls, patients with mild cognitive impairment (MCI) and...

  • NEWS: ROUND UP. Dziedzic, Jessica // Neurology Reviews;Dec2006, Vol. 14 Issue 12, p4 

    The article offers news briefs related to brain diseases. In a survey of 3,681 stroke survivors, researchers found that patient younger than 65 reduced access to physician's care and medication. Drivers with Parkinson's disease may likely make mistakes than those with no neurologic disorders....

  • Shifts in Thinking About Dementia. Hachinski, Vladimir // JAMA: Journal of the American Medical Association;11/12/2008, Vol. 300 Issue 18, p2172 

    The author reflects on changes which have been seen in the way that medical professionals think about dementia. He suggests that the concept of dementia, for ascertaining and addressing cognitive impairment has failed and that the concept of dementia is obsolete. He argues that cerebrovascular...

  • Dementia and Cerebrovascular Disease. Knopman, David S. // Mayo Clinic Proceedings;Feb2006, Vol. 81 Issue 2, p223 

    Cerebrovascular disease is an important cause of cognitive impairment and dementia in elderly patients. This review highlights the challenges involved in examining the role of cerebrovascular disease in dementia, areas in which consensus is emerging, and an operational framework for clinicians....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics